BENLYSTA (BELIMUMAB) — FDA Approval BLA761043 (GLAXOSMITHKLINE LLC)
BENLYSTA (BELIMUMAB) — FDA Approval BLA761043 (GLAXOSMITHKLINE LLC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: BENLYSTA; Active ingredients: BELIMUMAB; Application number: BLA761043.
| Brand name | BENLYSTA |
|---|---|
| Active ingredients | BELIMUMAB |
| Application number | BLA761043 |
| Sponsor | GLAXOSMITHKLINE LLC |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20170720 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →